Neva Haites

Q: What Schools Are Affiliated With Neva Haites

Neva Haites is affiliated with the following schools: University of Melbourne, University of Adelaide, University of Aberdeen

Neva Haites's AcademicInfluence.com Rankings

Neva Haites

Biology

#10458

World Rank

#13791

Historical Rank

Genetics

#1117

World Rank

#1216

Historical Rank

biology Degrees

Download Badge

Biology

Neva Haites's Degrees

Bachelors Genetics University of Melbourne

Why Is Neva Haites Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Neva Haites OBE FRSE FMedSci is a scientist and physician who investigates molecular genetics and diseases in humans and specialises in cancer genetics; she has more than 90 publications in genetics concerning inherited predisposition to cancer, retinitis pigmentosa, hereditary motor neuropathy and sensory neuropathy.

(See a Problem?)

Neva Haites's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. (1998) (700)
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype (2005) (667)
Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study (1996) (422)
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. (1998) (371)
To tell or not to tell: barriers and facilitators in family communication about genetic risk (2003) (354)
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study (2007) (299)
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. (1997) (278)
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. (2000) (239)
Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies (1999) (219)
Prothrombotic Genotypes Are not Associated with Pre-eclampsia and Gestational Hypertension: Results from a Large Population-based Study and Systematic Review (2002) (204)
Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1) (1994) (189)
p53 mutation is a common genetic event in ovarian carcinoma. (1993) (189)
Family Communication about Genetic Risk: The Little That Is Known (2004) (165)
Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study (2006) (158)
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer (2001) (143)
Paget's Disease of Bone: Evidence for a Susceptibility Locus on Chromosome 18q and for Genetic Heterogeneity (1998) (139)
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). (2002) (128)
Comparative genomic hybridization and chromosomal instability in solid tumours (1999) (127)
Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy (2002) (119)
Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. (1996) (114)
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. (1998) (113)
Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study (2007) (109)
Residual Ataxia Telangiectasia Mutated Protein Function in Cells from Ataxia Telangiectasia Patients, with 5762ins137 and 7271T→G Mutations, Showing a Less Severe Phenotype* (2001) (100)
Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. (2005) (100)
Assessment of cardiac output by the Doppler ultrasound technique alone. (1985) (97)
Method of assessing the reproducibility of blood flow measurement: factors influencing the performance of thermodilution cardiac output computers. (1986) (96)
Patient and general practitioner delays in acute myocardial infarction (1988) (93)
Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. (1992) (92)
Induction of nitric oxide synthase in human mesangial cells. (1993) (88)
Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening (1995) (82)
Aortic blood velocity measurement in healthy adults using a simple ultrasound technique. (1983) (81)
Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation (2000) (74)
Assessing patients' participation and quality of decision-making: insights from a study of routine practice in diverse settings. (2004) (74)
Significant telomere shortening in childhood leukemia. (1992) (73)
Repeated freezing and thawing of peripheral blood and DNA in suspension: effects on DNA yield and integrity. (1990) (73)
Adhesion molecule interactions in human glomerulonephritis: importance of the tubulointerstitium. (1996) (68)
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia (2003) (63)
Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer (2002) (61)
One thousand heart attacks in Grampian: the place of cardiopulmonary resuscitation in general practice. (1987) (60)
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. (2002) (58)
Human fetal testis Leydig cell disruption by exposure to the pesticide dieldrin at low concentrations. (2007) (57)
Familial breast cancer: an investigation into the outcome of treatment for early stage disease (2004) (57)
Reproducibility of linear cardiac output measurement by Doppler ultrasound alone. (1986) (57)
Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case–control study in a population with relatively low folate intake (2008) (56)
Colorectal cancer genomics: evidence for multiple genotypes which influence survival (2001) (55)
Autosomal dominant retinitis pigmentosa (ADRP): a rhodopsin mutation in a Scottish family. (1992) (52)
Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism? (1994) (52)
3rd Workshop of the European CMT consortium: 54th ENMC International Workshop on Genotype/Phenotype Correlations in Charcot-Marie-Tooth Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies28–30 November 1997, Naarden, The Netherlands (1998) (51)
The expression of connexin 43 in human kidney and cultured renal cells. (1997) (51)
Upregulation and co‐localization of connexin43 and cellular adhesion molecules in inflammatory renal disease (1997) (50)
A Scottish family with Bazex-Dupré-Christol syndrome: follicular atrophoderma, congenital hypotrichosis, and basal cell carcinoma. (1996) (50)
Human fetal testis: second trimester proliferative and steroidogenic capacities. (2000) (50)
CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations. (2000) (49)
HOW FAR IS THE CARDIAC OUTPUT? (1984) (49)
‘It's their blood not mine’: Who's responsible for (not) telling relatives about genetic risk? (2005) (49)
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. (2002) (46)
Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism. (1998) (45)
p53 mutation and expression in lymphoma. (1995) (45)
CD44 in glomerulonephritis: expression in human renal biopsies, the Thy 1.1 model, and by cultured mesangial cells. (1996) (42)
Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells. (1993) (41)
Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies. (1999) (41)
Endocrine disrupting chemicals: effects on human male reproductive health. (2001) (40)
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). (2002) (40)
Preimplantation diagnosis or chorionic villus biopsy? Women's attitudes and preferences. (1993) (40)
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. (2004) (40)
Asthma, wheezy bronchitis, and atopy across two generations. (1999) (39)
Impairment of colour vision in workers exposed to organic solvents (2000) (39)
Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors. (1998) (39)
p53 mutation in the myelodysplastic syndromes (1995) (38)
Stroke and minute distance in pregnancy: a longitudinal study using Doppler ultrasound (1987) (38)
The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing. (1993) (37)
A case‐control study of Parkinson's disease and tobacco use: Gene‐tobacco interactions (2010) (37)
Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines. (2005) (36)
Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk. (2006) (35)
Utilisation of Prophylactic Mastectomy in 10 European Centres (2002) (35)
Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception (2011) (34)
Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics (2002) (33)
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials (2006) (32)
Linkage in a family with X‐linked Charcot‐Marie‐Tooth disease (1989) (31)
The significance of p53 mutation and over‐expression in ovarian cancer prognosis (1996) (29)
Variation of phenotype in patients with glucocorticoid remediable aldosteronism. (1996) (29)
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. (1999) (29)
Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer (2002) (27)
Ethical, Social and Economic Issues in Familial Breast Cancer: A Compilation of Views from the E.C. Biomed II Demonstration Project (2002) (27)
Haemochromatosis mutations in North‐East Scotland (1999) (26)
Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells. (1997) (26)
Organic solvent exposure, genes, and risk of neuropsychological impairment. (2002) (26)
Inactivation of the p16INK4A gene by methylation is not a frequent event in sporadic ovarian carcinoma. (2001) (24)
Ascertainment of myotonic dystrophy through cataract by selective screening. (1995) (24)
Regulation of alternative splicing of the fibronectin IIICS domain by cytokines. (1994) (23)
Doppler ultrasound measurement of cardiac output. (1984) (23)
Teaching undergraduates about familial breast cancer: comparison of a computer assisted learning (CAL) package with a traditional tutorial approach (2001) (21)
Heterogeneity and molecular weight inter-relationships of the esterase isoenzymes of several invertebrate species. (1972) (21)
Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study (2009) (21)
Advances in Charcot–Marie–Tooth Disease Research: Cellular Function of CMT-Related Proteins, Transgenic Animal Models, and Pathomechanisms (1997) (21)
Blood pressure in relation to birth weight in twins and singleton controls matched for gestational age. (2003) (20)
X linked Charcot-Marie-Tooth disease (CMTX1): a study of 15 families with 12 highly informative polymorphisms. (1994) (20)
Phenotypic analysis of the glomerular and periglomerular mononuclear cell infiltrates in the Thy 1.1 model of glomerulonephritis. (1995) (19)
Dietary intake of folate and related micronutrients, genetic polymorphisms in MTHFR and colorectal cancer A population-based case-control study in Scotland (2002) (19)
Rhodopsin mutations in a Scottish retinitis pigmentosa population, including a novel splice site mutation in intron four. (1994) (19)
Outcome of children of parents with atopic asthma and transient childhood wheezy bronchitis. (1997) (19)
Epidemiology and genetic theories in the etiology of congenital talipes equinovarus. (1999) (18)
A survey of the current clinical facilities for the management of familial cancer in Europe (2000) (17)
Management of Hereditary Breast Cancer (2002) (17)
Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. (1994) (16)
Evaluation of laboratory methods for cystic fibrosis carrier screening: reliability, sensitivity, specificity, and costs. (1994) (16)
Endocrine disrupting chemicals (2001) (15)
Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1α gene: implications for predictive testing (1999) (15)
Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP). (1995) (15)
Cancer Genetics Services in Europe (2002) (15)
Breast cancer in two sisters with Friedreich's ataxia. (2001) (15)
Partial trisomy 7 (q32----qter) syndrome in two children. (1986) (15)
Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models (2007) (14)
Interleukin-1β up-regulates the plasminogen activator/plasmin system in human mesangial cells (1996) (14)
Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe (2002) (14)
Prevalence of cystic fibrosis mutations in the Grampian region of Scotland. (1993) (12)
Linkage of a medium sized Scottish autosomal dominant retinitis pigmentosa family to chromosome 7q. (1996) (12)
Linkage studies with 17q and 18q markers in a breast/ovarian cancer family. (1993) (12)
Screening for cystic fibrosis (1991) (12)
Convenient monitoring of cardiac output and global left ventricular function by transcutaneous aortovelography — an update (1986) (11)
Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia (2004) (11)
An Immunohistological Study Of Epidermal Growth Factor Receptor And Neu Receptor Expression In Proliferative Glomerulonephritis (1993) (11)
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2‐year‐old girl with familial adenomatous polyposis (1996) (11)
Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours. (1996) (10)
The multidisciplinary management of a family with epithelial ovarian cancer (1992) (10)
Variation in mortality from ischaemic heart disease between England and Scotland. (1987) (9)
Cardiac output in twin pregnancy. (1985) (8)
Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes (2002) (8)
A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer. (1999) (8)
A new approach to prenatal cystic fibrosis carrier screening. (1993) (8)
Effect of B vitamins and genetics on success of in-vitro fertilization : Prospective cohort study (2006) (7)
Stored tissue may be important for the future care of families (2001) (7)
Guidelines for regional genetic centres on the implementation of genetic services for the breast, ovarian and colorectal cancer families in Scotland (2000) (7)
A Rapid Method of Screening for N-Acetyltransferase (NAT2) Phenotype by Use of the WAVE DNA Fragment Analysis System (2003) (7)
Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations (2000) (7)
Acylcarnitine analysis in the investigation of myopathy (1998) (7)
Familial Breast and Ovarian Cancer: Overview of the clinical genetics of breast cancer (2002) (7)
An immunohistological study of epidermal growth factor receptor and neu receptor and neu receptor expression in proliferative glomerulonephritis. (1993) (6)
Online medical genetics resources: a US perspective (2001) (6)
Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells. (1997) (6)
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. (1996) (6)
Genetic aspects of Charcot-Marie-Tooth disease (1998) (6)
Genetic prediction of adult onset disease (1994) (5)
Transforming growth factor beta (TGF-beta) regulates the matrix-associated plasminogen activator inhibitor 1 (PAI-1) in glomerular mesangial and epithelial cells. (1995) (5)
Familial Breast and Ovarian Cancer: Guidelines for the development of cancer genetics services (2002) (5)
Rhodopsin splice site sequence changes in retinitis pigmentosa and their effect at the mRNA level (1998) (5)
British Society of Human Genetics (2002) (5)
Risk estimation for familial breast cancer: improving the system of counselling (2007) (5)
Screening for cystic fibrosis. Author's replies (1991) (4)
Antenatal cystic fibrosis carrier screening--whether, when and how? (1993) (4)
Novel 5 bp germline deletion in exon 11 of the BRCA1 gene (1998) (4)
Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria? (2002) (4)
Annex VIII : Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception : update (2013) (4)
Familial breast cancer: some social, economic and ethical issues (2000) (4)
Thy1 Glomerulonephritis Induced in Young Lewis Rats Accelerates Age-Related Glomerulosclerosis (2001) (4)
A genetic linkage study of a family with Norrie's disease (1988) (3)
Sequential occurrence within three years in a premenopausal woman of cervical, ovarian, and endometrial cancers (2001) (3)
Increased fibronectin incorporation into extracellular matrix in response to platelet-derived growth factor is mediated by transforming growth factor beta. (1995) (3)
Start a DNA diagnostic service. (1988) (3)
Screening for familial ovarian cancer (2002) (3)
Male breast cancer: the importance of recognizing family history and the preliminary results of linkage analysis to BRCA1 and BRCA2 (1996) (3)
Does breast cancer genetic counselling meet women's expectations? A qualitative study (2006) (3)
Immunohistochemical detection of a germline BRCA1 mutation in a breast and ovarian cancer family. (2000) (3)
Sources of DNA for studying gene-nutrition interactions. (2002) (3)
Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells. (1996) (3)
Overview of the clinical genetics of ovarian cancer (2002) (3)
Prenatal diagnosis for the cystic fibrosis mutation 1717‐1, G→A using arms (1992) (2)
Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer (2003) (2)
The ethical management of genetic testing. (2003) (2)
Ectrodactyly-mandibulo-facial dysostosis: case report and delineation of an entity. (1992) (2)
Prenatal diagnosis for dystrophia myotonica using the polymerase chain reaction (1991) (2)
Genetic polymorphisms in folate metabolism, dietary folate intake and colorectal cancer: a population-based case-control study (2001) (2)
Proliferation and apoptosis in the developing human fetal testis: possible effects of endocrine disrupting chemicals (EDCs) (1999) (2)
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (2007) (2)
The peripheral neuropathies and their molecular genetics. (1997) (2)
Information recovery in cancer families: value for risk estimations (2007) (1)
A survey of the clinical facilities for the management of familial cancer in Europe: details of the current status (2000) (1)
Methodofassessing thereproducibility ofbloodflow measurement:factors influencing theperformance of thermodilution cardiacoutputcomputers (1986) (1)
Facial features in children with idiopathic congenital talipes equinovarus. (2009) (1)
Utilisation of Prophylactic Mastectomy in 10 (1999) (1)
Current breast screening services available throughout Europe to families at increased genetic risk for breast cancer (2000) (1)
Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic. (1996) (1)
Reply (1993) (0)
Service Breast Screening Programme (NHSBSP) (0)
Evidence for complete homozygosity of chromosome 17, containing a mutated p53 gene in a case of poorly differentiated ovarian serous adenocarcinoma (1992) (0)
Use of Linked Markers in Breast/Ovarian Cancer Families (1995) (0)
Screening for cystic fibrosis: medical and ethical issues (1993) (0)
Familial Breast and Ovarian Cancer: Future directions (2002) (0)
Vitamin D and breast cancer: interaction between dietary vitamin D and genetic variation in the vitamin D receptor may be implicated in the aetiology of breast cancer. (2001) (0)
Rhodopsin mutations in a Scottish retinitis pigmentosa (0)
cardiac output computers . the performance of thermodilution measurement : factors influencing reproducibility of blood flow Method of assessing the (0)
In vitro inhibition of colon cancer cell WiDR is not mediated through p53 and bcl2. (2004) (0)
Molecular genetics as a 'probe' in ophthalmology. (1993) (0)
Contents, Vol. 75, 1997 (1997) (0)
Subject Index Vol. 75, 1997 (1997) (0)
Pathology of the breast and ovary in mutation carriers (2002) (0)
Functional and structural analysis of the androgen receptor in Kennedy's disease (2001) (0)
Mutation-Specific Survival of Inherited Breast Cancer (2002) (0)
Comparative genomic hybridisation (CGH) identifies genetic events involved in bladder cancer progression. (2003) (0)
A model of progressive mesangio-proliferative glomerulonephritis. (1996) (0)
LOSS OF LIFE FROM HEART ATTACKS AT DIFFERENT AGES (1987) (0)
BRCA1 mutation analysis in Greek breast cancer families (2000) (0)
Cystic fibrosis screening policies (1996) (0)
Family communication about risk of hereditary breast/ovarian cancer (2002) (0)
Aberdeen Genetic Clinic (2004) (0)
CYSTIC FIBROSIS SCREENING POLICIES. AUTHOR'S REPLIES (1996) (0)
Prolonged elevation of glomerular total cellularity and cell density, but only late matrix accumulation, precede accelerated proteinuria in Thy1 glomerulonephritis (2000) (0)
1.4 Characteristics of patients with glucocorticoid remediable aldosteronism in the North East of Scotland (1997) (0)
sensitivity , specificity , and costs . fibrosis carrier screening : reliability , Evaluation of laboratory methods for cystic (0)
Advances in Brief Comparative Genomic Hybridization Analysis of Chromosomal Alterations Induced by the Development of Resistance to Thymidylate Synthase Inhibitors 1 (2006) (0)
F12: Characterisation of patients with glucocorticoid remediable aldosteronism in the North-East of Scotland (1997) (0)
Book reviews (1996) (0)
Assessment of risk estimation in women attending the Aberdeen Genetic Clinic with a history of breast cancer (2001) (0)
Are nurse counsellors an acceptable alternative to doctors in providing genetic counselling for breast cancer (2002) (0)
Establishing a normal baseline for immunohistochemical studies of the kidney. (1992) (0)
Enzyme polymorphisms as risk modifiers for solvent induced colour vision loss (1999) (0)
Comparative Genomic Hybridization Analysis of Chromosomal Alterations Induced by the Development of Resistance to Thymidylate Synthase Inhibitors1 (2006) (0)
52. Development of network of cancer family syndrome registries in eastern Europe (2001) (0)
History of a ‘Young Science’ (2005) (0)
Royal Society discussion meeting: Prevention and Avoidance of Genetic Disease, held on 29 to 30 April 1987 at the Royal Society. (1988) (0)
A linkage study of x linked dominant hereditary motor and sensory neuropathy hmsn with highly informative pericentric markers (1991) (0)
Management ofBRCA1/2mutation carriers (2002) (0)
A study of familial paget's disease in the U.K. (1995) (0)
Audit of Women Attending the Aberdeen Genetic Clinic with a Family History of Breast Cancer who Subsequently Develop Cancer (2002) (0)
Foreword by Helena Kennedy (2002) (0)
Familial Breast and Ovarian Cancer: Introduction (2002) (0)
Identification of women at high risk of breast cancer during attendance at NHSBSP (1993) (0)
Familial Breast and Ovarian Cancer: Management (2002) (0)
Patient andgeneral practitioner delays inacute myocardial infarction (1988) (0)
Gln15 missense mutation in the connexin 32 gene in a CMTX Italian family (1997) (0)
O-158. Developing new techniques to assess endocrine-disrupting chemical effects on human fetal testis (1999) (0)
The p21WAF1 gene is infrequently mutated in human ovarian tumours and p21WAF1 protein levels appear to be regulated independently of p53 status (1996) (0)
Patenting genes: a dangerous EU directive (2000) (0)
Society for Social Medicine and the International Epidemiological Association European Group (2001) (0)
Principles of molecular medicine: J. Larry Jameson (Editor) Humana Press (1156 pages), ISBN 0-896-03529-8, US $175, Hardcover (1998) (0)
Ascertainment ofmyotonic dystrophy through cataractbyselective screening (2011) (0)
Ovarian and breast cancer as part of hereditary non-polyposis colorectal cancer (HNPCC) and other hereditary colorectal cancer syndromes (2002) (0)
Teaching Breast Cancer Genetics to Medical Students: Evaluation of a Computer Assister Learning (CAL) Package (2002) (0)
Gene-diet interactions in the aetiology of colorectal cancer: results from a population-based case-control study in north-east Scotland (2006) (0)
Subject Index, Vol. 62, 1992 (2004) (0)
Beta-tubulin gene mutations and response to vinca alkaloids in acute lymphoblastic leukaemia (2000) (0)
A linkage study of x linked hereditary motor and sensory neuropathy hmsn with m27 beta (1991) (0)

This paper list is powered by the following services:

Other Resources About Neva Haites

en.wikipedia.org

What Schools Are Affiliated With Neva Haites?

Neva Haites is affiliated with the following schools:

Neva Haites's Academic­Influence.com Rankings